skip to primary navigationskip to content
 

SyndicateRoom takes its place in the Killer50

last modified Aug 07, 2014 12:56 PM
Equity crowdfunding company SyndicateRoom is one of 13 new entries in Business Weekly’s Killer50 list of the hottest technology companies in the East of England.
SyndicateRoom takes its place in the Killer50

Gonçalo de Vasconcelos

 

SyndicateRoom, based at ideaSpace, has helped a range of businesses raise cash to commercialise their projects through its unique model. It only lists companies already backed by professional business angels, who are investing their own money, and offers its members the same terms if they decide to invest alongside these professionals.

The company says it has democratised investment in young, fast-growing companies, helping companies to overcome the shortfall in capital usually associated with strong growth by allowing individuals to invest and become real-life ‘Dragons’.

And by subscribing members to the same share class and same rights as a business angel, SyndicateRoom ensures they are signing up to nothing less than the same deal as a professional investor.

Gonçalo de Vasconcelos, CEO of SyndicateRoom, said: “We are very pleased and honoured to have joined the Killer50 and be listed next to other amazing companies that inspire us to do better and think bigger every day. Joining such a list is great, but to make it to the list in one of the most entrepreneurial and successful areas of the world makes it feel extra special. We are absolutely thrilled!”

Also on the Killer50 list is Cambridge Intelligence, the firm responsible for the KeyLines data visualisation toolkit. It is one of a growing number of ideaSpace alumni and it moved into its own offices on Cambridge’s Regent Street earlier this year.

For the full article and the Killer50 list see here.

RSS Feed Latest news

GeneAdviser partners with Birmingham Women’s Hospital to make personalised medicine more accessible

Sep 29, 2016

The largest genetics laboratory in the NHS brings to the platform their solid tumour sequencing, enabling clinicians to give an individual approach to their patients, tailored to their tumour’s genetic makeup.

GeneAdviser raises £350K to boost uptake of genomic medicine

Jun 02, 2016

GeneAdviser, an online ordering platform for clinical genetic testing, has raised £350,000 in its first round of seed funding, backed by Cambridge biotech angel Dr Jonathan Milner.

ROADMAP Systems secures $1.7m in Series A investment

Apr 08, 2016

ideaSpace member and ROADMap CEO Karl Heeks ready to take revolutionary wavelength switch technology to market

Metrarc wins funding from Innovate UK for data protection research

Mar 31, 2016

Cambridge-based Metrarc is part of a consortium which has won funding worth nearly £400,000 from Innovate UK to combat growing security threats to the management of personal health data.

View all news